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CancerP120-catenin is essential to vertebrate development, modulating cadherin and small-GTPase functions, and
growing evidence points also to roles in the nucleus. A complexity in addressing p120-catenin's functions is its
many isoforms, including optional splicing events, alternative points of translational initiation, and secondary
modiﬁcations. In this review, we focus upon how choices in the initiation of protein translation, or the earlier
splicing of the RNA transcript, relates to primary sequences that harbor established or putative regulatory
phosphorylation sites. While certain p120 phosphorylation events arise via known kinases/phosphatases and
have deﬁned outcomes, in most cases the functional consequences are still to be established.
In this review, we provide examples of p120-isoforms as they relate to phosphorylation events, and thereby to
isoformdependent protein–protein associations and downstream functions.We also provide a view of upstream
pathways that determine p120's phosphorylation state, and that have an impact upon development and disease.
Because othermembers of the p120 subfamily undergo similar processing and phosphorylation, aswell as related
catenins of the plakophilin subfamily, what is learned regarding p120 will by extension have wide relevance in
vertebrates.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Together with cell interactions taking place with the extracellular
matrix (e.g. integrin-mediated), varied cell–cell adhesion complexes
contribute to development and tissue homeostasis. In vertebrate
epithelial cells, three major types of cell–cell contacts tend to be
discussed, including adherens, tight and desmosomal junctions. Given
our focus upon p120-catenin, we note that it was initially characterized
as a substrate of the Src kinase [113], and shortly thereafter was found
in association with one of the principal transmembrane components
of epithelial adherens junctions, E-cadherin [1,100,111]. Adherens
junctions are complex both with respect to the number of components
involved, and the kinds of outside-in and inside-out (etc.) signals trans-
duced or facilitated. Two of an assortment of proteins able to bind to the
cytoplasmic carboxyl-tails of classic cadherins include p120-catenin and
β-catenin. Within the p120 subfamily of catenins are ARVCF-, δ- and
p0071-catenin; each competes with the other as well as with p120-
catenin itself to bind a membrane-proximal site on the cadherin tail
[17,54,86]. β-catenin (or the related γ-catenin/plakoglobin) binds to amccrea@mdanderson.orgmore membrane-distal site on the tail, indirectly linking the cadherin
complex to the contractile cortical-actin cytoskeleton, an interaction
that contributes to cell adhesion and motility [91,135].
As noted, p120-catenin was originally described as a Src kinase
substrate, and then as a component of the cadherin–catenin complex.
P120-catenin promotes cadherin stability, lowering the complex's sus-
ceptibility to endocytosis, ubiquitination, and proteosomal destruction
[25,33,56,92,149,150]. With the exception of αE-, αN- and αT-catenin,
which are structurally related to vinculin, all catenins including p120
contain a central Armadillo-repeat domain that facilitates protein–
protein interactions. The Armadillo domain is onlymodestly homologous
between p120 subfamily catenins (45–55% primary sequence identity),
and the amino- and carboxyl-terminal regions are yet more divergent.
In addition to binding and modulating E- or other classic-cadherins,
p120-catenin regulates small-GTPases (e.g. Rac1 and RhoA). This can
occur while p120 is associated with or dissociated from the larger
cadherin–catenin complex [6,69–71,144]. P120 can bind small-GTPases
as a guanine-nucleotide dissociation inhibitor/GDI (e.g. for RhoA), or
associate indirectly via GEFs, GAPs or other small-GTPase effector pro-
teins. P120-catenin further associates with microtubules and motor
proteins [23,43,155]. A ﬁnal intriguing property of p120-catenin relates
to its nuclear entry and association with transcriptional regulators such
as Kaiso [30,31,108], Glis2 [51] and REST/CoREST [77]. In particular,
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naling [49]. In summary, p120 binds and regulates the cadherin–catenin
complex (cell–cell junctions), small-GTPases and cytoskeletal factors
(cell–cell junctions and elsewhere), and transcription factors (nucleus).
Thus, we will address in this review how p120's phosphorylation and
isoform status is relevant to an array of cellular processes.
P120-catenin's phosphorylation, isoform status and intracellular lo-
calization vary with the cell type and tissue (reviewed in [70,107,114].
With respect to nuclear localization, p120 was initially suggested to
contain two nuclear localization signals (NLS) [2,7], and three potential
nuclear-export (NES) regions (Fig. 1) [137]. The NLS sequence between
Armadillo repeats 5 and 6 modulates p120's (isoform 1) nuclear locali-
zation [63], although other ﬁndings have instead pointed to p120's
(isoform 3) Armadillo region in nuclear entry (repeats 3 and 5) or
export (repeat 8) [114]. For example, the Armadillo domain of p120
appears needed for it to shuttle into the nucleus in response to Rac1
[76]. Also favoring p120 nuclear entry is the transcription factor Glis2,
especially in combination with Src phosphorylation of p120 [51].
At cell–cell contacts such as adherens junctions, p120 interacts with
E- and other cadherins, with either's phosphorylation affecting their
association [36,38,44,104,138]. Thus, as we will discuss in the contextFig. 1. P120-catenin structural features. Structural features of human p120-catenin in relation
alternatively spliced regions (tan boxes A-D), and subcellular localization signals (NLS black box
main is depicted in green; and in the case of p120-catenin and related sub-familymembers, it ha
nuclear localization sequences (NLS) [2,63,114], and nuclear export sequences (NES) [137]. An a
Additional information on the functional differences between p120-catenin isoforms is included
actions of p120-catenin are included within the ﬁgure itself.of p120's isoform-speciﬁcity, its phosphorylation and protein–protein
interactions help to determine p120's intracellular localizations and
functions.
2. Isoforms of p120-catenin
Considering combinatorial possibilities that result from four distinct
translation-initiation sites and four alternatively spliced exons, human
p120-catenin possess in theory 64 primary-sequence isoforms (Fig. 1)
[62]. P120-isoform 1 is the product of the most upstream translational
initiation. It contains an amino-terminal coiled-coil domain, absent
from isoforms 2 to 4. Isoform 4 is missing almost the entire amino-
terminus of p120-catenin, thus lacking the coiled-coil as well as a regu-
latory region harboring many potential or conﬁrmed phosphorylation
sites [147]. P120-isoform 2 and -isoform 3 lack smaller regions, perhaps
most noteworthy being the amino-terminal coiled-coil region that
enables some of p120's interactions (Fig. 1). The differential functions
of p120's isoforms are just beginning to be revealed, such as in the regu-
lation of RhoA activity [154]. As noted, varying p120-isoforms are
expressed in different ratios among varying cell types or contexts [94].
With the exception of macrophages [156], non-adherent (e.g. B- and T-)to its direct interaction partners, alternative translational start sites (yellow boxes 1–4),
es; NES red boxes). An alternatively spliced region D is rarely excluded. The Armadillo do-
s nine repeat units each of about forty-two amino acids. Indicated are a number of putative
mino-terminal coiled-coil region is shown in light blue and exists solely in p120-isoform 1.
in the review text, while representative references relating to the indicated protein inter-
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mesenchymal transition/EMT, (e.g. promoted via the expression of
Snail, c-Fos, SIP1/ZEB2, Slug, Twist or Zeppo1), switches have been ob-
served from p120-isoform 3 to isoform 1 [20,99,118,125]. Mechanisms
governing the ratio of p120's primary-sequence isoforms have been
partially clariﬁed through work upon RNA splicing factors such as
ESRP1 and ESRP2 [141] (Fig. 3B). Studies also point to p120-isoform 1
more so than isoform 3 in cancer cell invasion and metastasis [89,125,
127,131,153,154,158,161].
In addition to four distinct translation initiation sites, p120 contains
four alternative spliced exons, denoted A, B, C and D (Fig. 1). Exons A
and C are respectively 21 and 6 amino acids long andnotwell character-
ized, while exon B's 29 amino acids appear to encode a nuclear export
sequence (NES) [2]. Exon D (24 amino acids) is almost always present
[107], with for example, early reports including its inclusion in fetal
and adult brain tissues [3]. No potential phosphorylation sites exist
within these splice insert regions, although potential sites are nearby.
For example, S879 and S873 adjoin exon A, and S916 resides between
exons A and B (Fig. 1). Conceivably, the presence versus absence of
oneof these exons couldmodulate phosphorylation-dependent interac-
tions nearby.
P120-catenin's function is also modulated through subcellular local-
ization, likely to be inﬂuenced by primary-sequence elements present
(or absent) in distinct p120-isoforms. An example was provided above
with p120 nuclear export (cytoplasmic localization) being enhanced
by the NES in isoform B (Fig. 1). Residues that instead reside within
p120's amino-terminusmay also have a role in determining p120 local-
ization. For example, a larger proportion of isoform 3 than 1 (Fig. 1)
enters the nucleus in cells in contact with matrix and grown in 3-D
[125]. In turn, isoform 1 may be directed to cell–cell contacts and
elsewhere via interactions at its very amino-terminus [85]. As discussed
later, distinguishing phosphorylation sites reside in amino-terminal
(translational) isoforms of p120, as well as potentially, sequences
ﬂanking p120's optional splice inserts.
E-cadherin binds p120's central Armadillo domain at adherens
junctions in normal epithelial cells, where p120 promotes cadherin
clustering and adhesive function [157]. This occurs in part via p120's en-
hancement of cadherin stability at cell–cell contacts [25,33,56,57,92,
149,150]. In turn, multiple p120-isoforms as well as other Armadillo
catenins would be predicted to be modulated via sequestration
by cadherins. It is interesting that in the case of the structurally related
β-catenin, reports have suggested to varying extents that its amino-
or carboxyl-terminal tails fold in cis to affect associations of the
Armadillo-domain in trans [93,26]. If this likewise applies to p120,
then one can imagine that p120-isoforms 1 to 4, with distinctions in
length and phosphorylation potential, may vary in their capacity to
modulate p120's Armadillo-domain interactions.
3. Phosphorylation of P120-catenin
Phosphorylation is one of many modiﬁcations impinging upon
protein interactions and subcellular localization. Known as well as
putative phosphorylation sites exist in the amino-terminal region of
p120-catenin [4]. To our knowledge, no other secondary modiﬁcations
with the exception of ubiquitination [49] have been evaluated. As
addressed below with respect to canonical Wnt signaling, key residues
are phosphorylated in the amino-terminus of p120-isoform 1 (Fig. 1)
[49]. With regards to other parts of p120, such as the Armadillo or
carboxyl-tail domains, other kinases or phosphatases are capable of
making modiﬁcations in less isoform-speciﬁc manners.
Since the varied isoforms of p120modulate cadherins, small-GTPases
and gene targets, they are relevant to development, homeostasis and
disease progression. Such isoforms localize differentially and according
to context, with phosphorylation altering p120's protein interactions,
cytoplasmic-nuclear shuttling and nuclear activity. It is thus relevant to
probe the isoform-speciﬁc roles of p120 as a function of phosphorylation.3.1. Phosphorylation speciﬁc to p120-isoform 1
Recent work has identiﬁed four conserved serine phosphorylation
sites at the very amino-terminus of p120-isoform 1 (S4, 8, 11, 15)
(Fig. 1). The closely-spaced serines comprise a “destruction box” similar
to that in β-catenin [49] (reviewed in [129]). These sites become
phosphorylated by CK1α and GSK3β when canonical Wnt pathway
activity is lacking, resulting in reduced catenin stability and thus
reduced signal transduction to the nucleus (Fig. 3A). In the case of
p120, nuclear partners include the transcriptional regulators Kaiso [30,
31,108], Glis2 [51], and REST/CoREST [77]; these associated factors are
each distinct from the transcriptional regulators binding β-catenin
(e.g. TCF/LEF). Of p120's partners, only Kaiso has been shown thus far
to respond (via p120) to canonical Wnt signals [49,101,102,121]. As
would be expected, isoform 1 is the most sensitive to the activity of
canonical Wnt pathway components such as LRP5/6. An additional
phosphorylation site in isoform 1 was resolved immediately after the
coiled-coil domain (S47), phosphorylated by the kinase Dyrk1A.
Interestingly, in opposition to CK1α and GSK3β, the phosphorylation
of p120-isoform1 byDyrk1A enlarges the “signaling pool” of p120 to pro-
mote its activity in the nucleus, as well as conceivably, p120's modulation
of small-GTPases and the cytoskeleton. In Xenopus and human cell lines,
Dyrk1A's phosphorylation of p120-isoform 1 enhances canonical Wnt
signaling [50]. For example, in a classic assay of Wnt activity in vivo,
ventral co-expression of a phospho-mimic of p120-isoform 1 (T47D)
enabled an otherwise sub-phenotypic dose of exogenous β-catenin to
produce ectopic dorsal axes in Xenopus embryos. Recent work has fur-
thermore identiﬁed DIPA as a binding partner speciﬁc for p120-isoform
1 [69,84,85], and an amino-terminal region preceding p120's coiled-coil
domain is an important binding site for kinesin (Fig. 1). Given that other
proteins associate with p120's amino-terminal region, such as NLBP,
PLEKHA7 and RPTPμ, future tests must assess the isoform speciﬁcity of
these interactions [23,64,71,72,85,87,109].
3.2. Phosphorylation speciﬁc to p120-isoforms 1 and 2
There is only one potential phospho-tyrosine (Y96) between the
second and third translational initiation sites of p120 (Figs. 1 & 2) [4],
as well as three serines (S81, S92 and S97). These sites, however, are
only weakly scored when using algorithms to predict phosphorylation
(e.g. NetPhosph 2.0). Currently, no evidence suggests Y96 affects p120
function, but Y96 is phosphorylated by an unknown kinase in Src
transformed cells [82]. Fer, a member of the Src tyrosine-kinase family,
preferentially associates with the two longer isoforms of p120 [115].
While only one tyrosine residue selectively resides in isoforms 1 and 2
(Y96), it could conceivably provide an opportunity for tyrosine kinases
such as Fer to regulate p120-isoforms 1 and 2 in the context of cadherins,
small-GTPases or other protein complexes. Further study is warranted of
the kinase(s) and phosphatase(s) involved at these tyrosine and serine/
threonine sites.
3.3. Phosphorylation speciﬁc to p120-isoforms 1, 2 and 3
Many known or potential phosphorylation sites reside in the region
between the respective initiations of isoforms 3 and 4 (“regulatory
domain” mentioned in previous reviews [4]) [107,121,148] (Fig. 2).
Therefore, some of these sites are anticipated to provide shared effects
upon isoforms 1–3. P120 associates with kinases such as Fer, Fyn and
Yes [65,105,151], as well as interacts with a number of phosphatases
such as DEP1 [48], PTP-PEST [38], RPTPμ [162], RPTPrho [13], and SHP-1
[61], which are implicated in either modulating cadherin dependent cell
adhesion or motility, small-GTPases, or nuclear gene programs.
As mentioned previously, the larger sequence region upstream of
p120's Armadillo domain includes binding sites for partners such as
NLBP [64], PLEKHA7 [72,87,109], RPTPμ [162], DIPA [69,84,85], and Gα12
[8]. While validation remains needed in most cases, the phosphorylation
Fig. 2. Phosphorylation of p120-catenin. Outlined in the text are proposed kinases, phosphatases and signaling mechanisms modulating the level of p120-catenin phosphorylation. As
reﬂected in this ﬁgure, multiple residues are modiﬁed in response to serine, threonine (Red) or tyrosine (Blue ovals) kinases. Black circles indicate potential phosphorylation sites that
are not yet identiﬁed as phosphorylated, and that are not yet known to have functional effects. All four human translational start site isoforms are depicted (p120-isforms 1–4), so that
one can easily compare which phospho-residues in p120 pertain to only one versusmultiple isoforms. Given the number of phosphorylation sites involved, relevant references are included
in the review text, as opposed to this legend.
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someof these interactions or be a consequence of them, andwhile a num-
ber of phospho-sites currently appear to have lesser functional
implications [83], this could change upon applying other assays. Here,
we will ﬁrst discuss tyrosine and serine/threonine phosphorylation
events common to isoforms 1–3.
3.3.1. Tyrosine phosphorylation
P120was ﬁrst identiﬁed 20 years ago in a screen for novel substrates
of the Src kinase [113]. Depending on the context, heightened tyrosine
phosphorylation of cadherins and catenins has correlated with either
diminished [19] (e.g. via Fer kinase) [52,68,74,115,116], enhanced [16,
19,28,97,130], or little effect upon cell–cell junctions. Similar to tyrosine
phosphorylation, serine/threoninemodiﬁcation of p120 likewisemodu-
lates junction functions to context-dependent extents [12,98].
3.3.1.1. Src-family kinases. P120 is enriched in potential Src-family kinase
sites within its amino-terminal region (e.g. Y112, Y217, Y228) (Fig. 1).
This is one of two areas where RhoA binds [19,154]. Fyn's phosphoryla-
tion of p120 at Y112 diminishes p120's association with RhoA such that
RhoA is no longer inhibited (its activity rises), whereas Src phosphory-
lation of p120-catenin on Y217 and Y228 has the opposite effect, since
Src enhances p120's interaction to further inhibit RhoA. Recently,
the p120 dephospho- as opposed to phospho-form of Y112 was found
to associate with Rac and Vav2 to promote Rac activity and thereby
β-catenin nuclear localization, while Y217 dephosphorylation had
similar effects with regards to Rac [136] (Table 1). In common with
Src kinase, Fer also enhances p120:RhoA association, and both kinases
favor p120's association with E-cadherin [19] (Table 1). In another re-
port, p120's Y217 was shown to function in v-Src mediated reduction
of cell–cell adhesion in L-cells [100]. Collectively, theseﬁndings indicate
that functionally important phospho-residues reside with the amino-
terminal region of p120-catenin, lacking in isoform 4 (Fig. 1).
3.3.1.2. Receptor tyrosine kinases. The phosphorylation of adherens
junction components has also been studied in relation to the activitiesof receptor tyrosine kinases/RTKs such as EGFR, VEGFR and PDGFR
[37,39,55,83]. P120 Y228 is likely to be phosphorylated by EGFR signal-
ing, but this modiﬁcation occurs without obvious effects upon cell–cell
junctions when evaluated using epithelial cell cultures [83], and
appears not to be mediated via Src kinase. Thus, it is not currently
known if a particular p120-isoform(s) is preferentially regulated by an
RTK. With regard to non-receptor tyrosine kinases, as noted earlier,
Fer-kinase associates to an amino-terminal region of p120 (amino
acids 131–156), between p120's 3rd and 4th translational start sites
(Fig. 1) [65], with Src and Fyn sites mapped relatively nearby to Y112,
Y217 and Y228. Recently, the non-receptor tyrosine kinase PTK6
(Protein receptor tyrosine kinase 6) was found in association with
p120-catenin, although its phosphorylation of p120-catenin has yet to
be characterized [45].
In addition to the indirect activities of tyrosine kinases, there is also
the question of direct RTK phosphorylation of p120, and if particular
phospho-tyrosine residues display isoform-speciﬁcity. Unfortunately,
speciﬁc residues directly phosphorylated by EGFR, PDGFR or VEGFR
have yet to be resolved. Recent work using anti-VEGF antibodies points
to Y228 as being associated with glioblastoma progression [55,138].
This residue is phosphorylated by Src [82], often a downstream RTK
effector. Seven additional Src phosphorylation sites were identiﬁed,
with mutation of all eight sites (Y96, Y112, Y228, Y257, Y280, Y291,
Y296, Y302) eliminating p120's interaction with the phosphatase
SHP-1 [82]. Since p120-isoform 4 bound more poorly to SHP-1 than
did isoforms 1–3, it suggests that the greater number of Src-targeted
tyrosine residues within the amino-terminus of p120 may enable a
stronger SHP-1 association [61]. As phosphatases modulate many
biological outcomes including those at cell–cell contacts, differential re-
cruitment of SHP-1 (etc.) as determined by the p120-isoform present,
may be a means to modulate those outcomes.
In embryonal carcinoma cells, nerve growth factor or TrkA-receptor
stimulation leads to p120's (as well as β-catenin's) tyrosine phosphory-
lation, with these effects inhibited by the Src inhibitor PP2 [28]. The
residues involved are not known, a reﬂection of the work still needed
to identify and characterize p120's phospho-tyrosines.
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Given their regulation of p120's phosphorylation state, phospha-
tases are as central to our discussion as kinases. Phosphatases such as
SHP-1, SHP-2, DEP1 and RPTPμ act upon p120-catenin. For example,
the tyrosine phosphatase SHP-1 binds p120 following EGF-stimulated
p120-phosphorylation as mentioned [61], and SHP-1 effectively de-
phosphorylates Y296 and presumably additional residues following
the activity of Src [42] (Table 1). The tyrosine phosphatase DEP1 also as-
sociates with p120, although the phosphorylation sites it acts upon are
not known [48]. The RPTPμ tyrosine phosphatase binds p120 in a man-
ner independent of p120's central Armadillo domain (Fig. 1) [162]. In
most cases, thep120 tyrosine residues targeted by a particular phospha-
tase has yet to be determined. Better knowledge of both phosphatase
and kinase activity directed towards p120 should be useful in under-
standing p120's functions in junctional, cytoplasmic and nuclear con-
texts. More complete or reﬁned assays may also be required to assess
functional effects, since in many cases, negative experimental results
may not accurately reﬂect the in vivo signiﬁcance of the phospho-
residues examined, or that of the kinases or phosphatases acting upon
p120.
3.3.3. Serine/threonine phosphorylation
P120 is phosphorylated upon numerous serine/threonine residues,
with for example, effects reported for the PKC isoforms PKCα, PKCδ
[60] and PKCε [32]. PKC promotes phosphorylation of S879, and the de-
phosphorylation of S268, S288, T310 and T916 [15,138,147,148,160].
S268 is selectively present in p120-isoforms 1–3 and its phosphoryla-
tion is dependent upon one PKC isoform, PKCε. Phosphorylation of
S288 in response to PKC promotes the binding of p120-isoform 3 to
the transcription repressor Kaiso, its movement from the nucleus to cy-
toplasm and presumably gene targetmodulation [160] (Fig. 3C). Nearby
to S288, residues S268 and S269 are likewise phosphorylated. Here,
CK1ε responds to canonical Wnt pathway activation, with p120 phos-
phorylation via CK1α somehow promoting p120's release from
cadherin [18] (Table 1). This increases p120's signaling pool, with
S268 and S269 phosphorylation promoting p120's association with
the Kaiso transcriptional regulator to activate (relieve repression of)
gene targets [36], aswell as activating Rac. The author'smodel proposes
interaction of the cadherin-complex with the Wnt-pathway receptor
complex, integrating their signaling to the nucleus. As the serine resi-
dues discussed (S268, S269 and S288) are present only in isoforms 1–
3, they alone would be expected to participate in such a pathway.
While EGFR, VEGFR or PDGFR activation enhances p120's tyrosine
phosphorylation [37,39], VEGFR has also been noted to promote the de-
phosphorylation of p120 upon serine/threonine [145]. This effect is
thought to occur through downstream effects upon PKC and ultimately
an unidentiﬁed phosphatase. Dephosphorylation of p120 also occurs in
cells exposed to potentiators of PKC (e.g. phorbol esters), with effects
observed upon S268, T310 and T916 in addition to other residues
[139,147,148]. P120 is alternatively phosphorylated upon serine/threo-
nine residues following activation of RTKs (e.g. PDGFR), with the effects
again being in part due to the downstream engagement of PKCα [15,
138]. For example, S879 is directly or indirectly phosphorylated by
PKCα. S879 is just upstream of the A splice-isoform insert in p120-
catenin (Figs. 1 & 2), so their juxtaposition may be relevant to either
isoforms's functional activities in vivo.
3.4. Phosphorylated residues shared across p120-isoforms
Less is known concerning phosphorylation events in the Armadillo-
domain or carboxyl-tail of p120. TheArmadillo or carboxyl-tail region of
p120 interacts with multiple proteins such as MUC1, REST/CoREST,
Numb and p190RhoGAP, with these associations presumably being
shared among isoforms 1–4 [77–79,119,159].
In both p120's amino- and Armadillo-regions, phospho-serine,
-threonine and -tyrosine sites are present. Interestingly, the removalof p120's entire upstream region, as occurs naturally in generating iso-
form 4, eliminates multiple phosphorylation sites and associations in
this region, but not that with cadherins which instead involves p120's
neighboring Armadillo domain [57,98]. For example, PDGFR activation
leads to p120's phosphorylation at S879 via a PKCα-dependent path-
way [15]. Upon thrombin stimulation and thereby PKCα activation,
phosphorylation at S879 promotes p120's dissociation from VE-
cadherin. As might be predicted, S879 point-mutagenesis enhances
p120:VE-cadherin association and junction function, with a reduction
in cadherin endocytosis. Unlike PKCα's negative impact upon the asso-
ciation of p120 with VE-cadherin, and thus upon cell–cell interactions
[138], atypical-PKC promotes adhesion. This occurs through atypical-
PKC phosphorylation of Numb, and Numb's dissociation from the
carboxyl-tail of p120. Because Numb otherwise recruits α-adaptin,
Numb's loss reduces the extent of cadherin internalization [119]. It ap-
pears, therefore, that different PKC family members modify carboxyl-
tail residues within p120, exhibiting distinct effects upon p120 and
cadherin function.
Depletion of the phosphatase PTP-PEST results in enhanced p120
phosphorylation (Y335). This leads to reduced p120 association with
E-cadherin, with correspondingly greater p120 modulation of small-
GTPases and the cytoskeleton (via Vav2& cortactin), resulting inheight-
ened cell motility [38]. Since Y335 is present in all p120-isoforms
(Fig. 2), the downstream functional consequences of this relationship
with PTP-PEST might at ﬁrst seem to be shared. However, as noted ear-
lier, p120-isoform 1 is the most effective in inhibiting RhoA, such that
differences in isoform expression levels is likely to produce functional
distinctions.
4. P120-catenin isoforms and phosphorylation in development
P120-catenin has essential pleiotropic roles in vertebrate develop-
ment and homeostasis, while interestingly, it plays modulatory but
non-essential roles in invertebrates raised under laboratory conditions
(Drosophila & C. elegans) (reviewed in [86]). For example, in mice, the
whole animal knock-out of p120 is early embryonic lethal [34]. Addi-
tionally, several tissue speciﬁc knock-out mice have been generated,
such as in salivary gland, skin, teeth, dorsal forebrain, intestine, mam-
mary gland, eye, pancreas and endothelial cells [9,34,47,75,103,126].
Defects include those appearing at adherence junctions and in small-
GTPase functions (and likely gene-regulatory responses), with gross ef-
fects being manifest in aberrant tissue morphogenesis. P120 ablation in
different organ system reveals a variety of effects. In tissues such as skin,
salivary gland,mammary gland, dental enamel, kidney and vasculature,
p120 removal results in reduced E-cadherin levels, sometimes in con-
junctionwith inﬂammation [9,34,73,81,126]. During embryonic eye de-
velopment, p120 interacts functionally with Shroom3 in apical
constriction, with p120 removal disrupting lens pit invagination [75].
In addition, p120 in the context of neural crest cells contributes to
forming the eye and craniofacial skeleton [27,134,152]. In certain con-
texts other effects are observed. For example, p120 loss in the skin, in-
testine and pancreas promotes immune cell inﬁltration and
proinﬂammatory cytokine release [47,103,126]. Reports also suggest
p120 is tied to inﬂammation via effects upon small-GTPases, NF-κB ac-
tivity and Kaiso [21,53,110]. Recently, p120 ablation in mouse pancreas
progenitor cells produced embryonic defects in tubulogenesis,
branching morphogenesis and acinal cell differentiation, with concur-
rent inﬂammation [47]. Aberrant tubule formation was also reported
upon p120 loss during glomerulogenesis [81]. In Xenopus, p120
knock-down embryos exhibit gastrulation defects [41], with disrup-
tions arising due to defects in cadherin, small-GTPase and nuclear (e.g.
Kaiso) functions [49,66,102]. More information on p120's functions
during embryonic development is provided in prior reviews [86,106,
107].
Although p120-catenin is widely expressed, speciﬁc isoforms are
more apparent in certain tissue contexts. While not exclusive, the
107J.Y. Hong et al. / Biochimica et Biophysica Acta 1863 (2016) 102–114shorter p120-isoforms 3 or 4 are abundant in epidermis, palate and
tongue epithelia, and in the ducts of excretory glands, while longer
isoforms are favored at vascular-endothelial cell–cell junctions (blood
vessels), junctions of serosal epithelium lining internal organs, brain
choroid plexus, pigment epithelium of retina, and intercalated discs
of cardiomyocytes [2,90,95]. The isoform speciﬁc roles of p120 in
development are largely unknown. As discussed in this review, partial
differences in function presumably derive from isoform-speciﬁc distinc-
tions in the presence versus absence of regulatory phospho-residues.
Given that p120's phosphorylation-status is likely to have roles in
cadherin mediated cell–cell adhesion, cytoskeletal functions via the
modulation of small-GTPases, as well as signaling processes mediated
by canonical Wnt components or other pathways, it is appropriate to
postulate that deﬁned phosphorylation or dephosphorylation events
upon p120 are required in development.
As mentioned earlier, a number of reports indicate p120's involve-
ment in canonical Wnt signaling. Canonical Wnt signaling, which is
modulated by β-catenin, is central in development as well as tumori-
genesis. In recent reports, the kinases GSK3β, CK1α and Dyrk1A
phosphorylate p120-isoform 1 at deﬁned residues to regulate p120's
stability, which determines the size of its signaling pool [49,50]. The
same upstream canonical Wnt ligands and destruction-components
that act upon p120-isoform 1 also regulate β-catenin. An enlarged
signaling-pool of p120 promotes its binding to the transcription factor
Kaiso, and perhaps other transcriptional regulators. Although divergent
views have arisen [14,117], the association of p120 with Kaiso associa-
tion has been tied to the de-repression (activation) of p120/Kaiso
sequence-speciﬁc gene targets (KBS: TCCTGCNA) [66,102]. Further,
while a surprise at ﬁrst, the promoters of certain genes harbor binding
sites for both Kaiso and TCF/LEF, apparently to permit the coordinate
regulation of such genes by p120-catenin and β-catenin in response
to upstream Wnt-signals, potentially during embryogenesis [102]
(Fig. 3A). Given that GSK3β and Dyrk1A phosphorylation sites were
identiﬁed towards the amino-terminus of p120-isoform 1 (Table 1),
p120-mediated Wnt-responsiveness would be expected in those tis-
sues expressing isoform 1. Apart from this relationship, p120 partici-
pates in canonical Wnt signaling in other ways. For example, upon
upstream Wnt-pathway stimulation, p120 is phosphorylated on S268
and S269 by CK1α, while being dephosphorylated on tyrosine Y112
and Y217. The two serine phosphorylation events release p120 from
E-cadherin [18]. Upstream Wnt-activity further leads to phosphory-
lation upon E-cadherin and its release from the signalosome complex, fa-
voring GSK3β internalization (removal) and the activation of β-catenin
target genes [35,36,140]. Since S268, S269, S288, Y112, Y217 and Y228
exist in p120-isoforms 1–3, (but not in isoform 4), these effects may be
more general. The PKCα kinase instead phosphorylates p120 at S879,
promoting the dissociation of p120 from VE-cadherin in endothelial
cells, and the disassembly (enhanced permeability) of junctions [138].
As noted, PKC activity has also been observed to lower p120 phosphory-
lation (S268), presumably indirectly and occurring via an unknownphos-
phatase [148]. Since S879 and T916 exist in all isoforms of p120, their
examination might prove informative when considering isoform-wide
effects.
In another context, the dephosphorylation of p120 takes place via
RPTPμ, which acts upon tyrosines and is needed for proper p120 lo-
calization, as linked to adipocyte differentiation [67]. Thus, in re-
sponse to largely uncharacterized upstream signals, kinases and
phosphatases produce effects upon p120 that relate to its cellular lo-
calization and protein associations, and thereby to larger pathway
functions. While most of the current work has taken place in cell
lines, it points to experiments that must now be undertaken in de-
velopmental models. With respect to the focus of this review,
which examines phospho-residues that have isoform-selective ef-
fects, the developmental impact of a kinase or phosphatase will par-
tially depend on the particular p120-isoforms being expressed at
that time in a tissue.5. P120-catenin isoforms and phosphorylation in cancer
In multiple cancers such as adenocarcinoma, breast cancer, bladder
cancer and squamous cell carcinoma, reduced or relocalized p120
presence correlates with reduced E-cadherin presence, altered small-
GTPase activity and poor prognosis [58,112,124,131,143]. Recently,
p120-catenin cytoplasmic localization was correlated with poor
prognosis in human colon carcinoma and esophageal squamous cell
carcinoma [11,22]. Through p120's function in stabilizing cadherins,
consideration has been given to p120's activities as a tumor suppressor
[34,73,80,96,120,121,128,133]. For example, conditional deletion of
p120 in the mouse oral cavity, esophagus and forestomach results in
invasive squamous cell cancer in addition to desmoplasia and inﬂam-
mation [128]. P120's relationship to E-cadherin or other partners
is made more interesting by its isoforms having differing affects upon
tumor progression. Given its longer N-terminus, p120-isoform 1
(relative to isoform 3) exerts greater inhibition of RhoA. This can
enhance cell migration and invasion [123,127], with for example, p120-
isoform 1 expression being predictive of renal tumor micrometastasis
[154]. Since some phosphorylation sites are speciﬁc to p120-isoform 1,
they may in turn be relevant to normal or tumor cell migration. Other
work likewise points to distinctions in p120-isoform expression and
localization in pathology, as in the case of metastatic lung cancer [40,
123,161], breast invasive lobular carcinoma [122,123], and colon [11],
ovarian [24] and pancreatic cancer [132]. Some reports indicate that
cytosolic p120-catenin localization correlates with hyperplasia and the
progression of E-cadherin deﬁcient tumors (or E-cadherin mutant
tumors), and is predictive of poor prognosis [127] [11,22].
Given that differing p120-isoforms exhibit distinct localizations
according to context [2,114], choices involving isoform expression or
the presence of E- versus other cadherins is expected to play a role in
determining the roles of p120 in cancer. For example, in contrast to
p120's association with E-cadherin, that with P- or N-cadherin in
some instances promotes motility more so than adhesion [111,132].
Therefore, p120's contributions to pathology are likely to be determined
in part by what cadherins are expressed in the tumor [121].
Multiple phosphorylation sites reside in p120's amino- and carboxy-
terminal regions and may have a role in tumorigenesis. Utilizing
phospho-speciﬁc antibodies, cancer cell lines have been evaluated to
assess p120's phosphorylation state [83,147] (Table 1). E-cadherin
contributes to determining p120's phosphorylation in certain cancer
cell types, presumably by recruiting p120 into complexes or regions
rich in kinase activity [71,114,147].
Recently, upon Ras-PKCε activation in breast cancer cells, p120's
phosphorylation at S268 was found to contribute to cellular foci forma-
tion (Table 1). Another report found that p120-isoform 3 undergoes
S288 phosphorylation and greater Kaiso binding, correlating with
enhanced lung-cancer cell invasion in vitro [160,161]. While the work
above suggested that p120-isoform 3 was the prime modulator of
Kaiso function, ﬁndings from our group instead point to p120-isoform
1 being most responsive to canonical Wnt signals. Upon pathway
activation and in a manner analogous to β-catenin, p120-isoform 1 is
stabilized at the protein level. The model is that isoform 1 then enters
the nucleus to relieve (activate) Kaiso repressed gene targets [49,50].
Intriguingly, recent work on the whole genome level has indicated
that Kaiso is largely associated with transcriptional activation as
opposed to repression [14]; if this proves the case, it will be important
to establish if p120 additionally has a role in this context. As part of
earlier mentioned work, p120 phosphorylation at Y228 is predictive of
glioblastoma multiforme (GBM) invasiveness [55], and is also elevated
in invasive renal and breast tumors [71]. Further, T916 phosphorylation
is high in these tumors; and while the functional role of phospho-T916
was not resolved, it was found to obstruct the epitope of the widely
employed pp120monoclonal antibody. Thus,many past studies are likely
to have underestimated p120 levels in tumors. Further, tyrosine phos-
phatases such as PTP-PEST promote Y335's dephosphorylation and the
Table 1
Phenotypes related to p120-catenin phosphorylation.
Summary of observed phenotypes that relate to changes at a particular residue (column5); or changes to the kinase or phosphatase acting upon p120-catenin in the context of that residue(s) (column3). Indicated are the residue or residues involved
(column 1), the kinase or phosphatase involved (column 2), the signaling pathway implicated or proposed (column 4), and the p120-isoforms that are potentially affected. References are included (column 7; not comprehensive), with additional
references present within the review text.
Serine/Threonine
residue
Serine/Threonine
kinase
If undertaken, phenotype related to the kinase or
phosphatase, such as overexpression or depletion
Signaling pathway(s) Phenotype related to the phosphorylation site(s) P120
isoform(s)
containing
phos. Site
References
S6, S8, S11, S15 CK1α & GKS3β Gastrulation defects resulting from p120
overexpression are partially rescued via GSK3β
overexpression.
Wnt 4S- N 4A p120 point mutant is stabilized, w/
greater signaling capacity.
1 Hong...McCrea, J Cell Sci, 2010
T47 Dyrk1A Dyrk1A overexpression produces gastrulation defects
in Xenopus embryos, as well as facilitates β-catenin
induced duplicate axis formation.
Wnt P120 phospho-mimic point mutant is more
stable, w/ enhanced signaling capacity.
1 Hong...McCrea, J Cell Sci, 2012
S252, T310 GSK3β N/A N/A N/A 1, 2, 3 Xia...Reynolds, Biochemistry,
2003
S268, S288, T310, T916 PKC activation via PMA
results in the dephos.
of these four residues
N/A Serum starvation, LPA,
thrombin, PMA, VEGF
produces p120 dephos. via
effects upon PKC.
Cadherin-p120 association was not altered by
mutation of these phsopho-sites.
Phosphorylation of p120 required its membrane
assn.
1, 2, 3 Xia...Reynolds, Biochemistry,
2003 Xia...Reynolds, Exp Cell
Res, 2006 Wong...Staddon,
Biochem J, 2000
S268 PKCε PKCε overexpression leads to S268 phos., overcomes
contact inhibition and results in cellular foci
formation. PKCε depletion reverts Ras-induced
mesenchymal morphology.
N/A PKCε phenotype correlated with S268
phosphorylation, but mutant not tested.
1, 2, 3 Dann...Klippel, Oncogene,
2014
S268, S269 CK1α N/A Release of p120 from cadherin
and LRP5/6, Wnt pathway.
Phospho-deﬁcient point mutant S268A, S269A
failed to rescue gastrulation defect induced via
p120 depletion.
1, 2, 3 Del Valle-Perez...Dunach, Mol
Cell Biol, 2011 Vinyoles, Mol
Cell, 2014 Valls...Dunach, J Cell
Sci, 2012
S288 PKC S288 phosphorylation is high In lung cancer cell lines,
primary cells and tissues.
P120-isoform3 recruits Kaiso
to the cytoplasm.
Cell invasion is regulated by S288 in lung cancer
cell lines (S288E mutant was utilized).
3 Zhang...Wang, Int J Oncol, 2011
S252, T310 GSK3β (in vitro) N/A N/A N/A 1, 2, 3 Xia...Reynolds, Biochemistry,
2003
S879 PKCα PKCα induced p120 dissociation from VE-cadherin
and AJ disassembly.
PKCα depletion reduces thrombin-induced decreases
in transendothelial electric resistance.
Thrombin/Par-1 and
LPS-induced lung vascular
permeability (2012)
PDGF (2009)
P120 point mutants (S879A or S879D) indicate
direct effects (2012),
Correlated to the PDGF signaling (2009).
1, 2, 3, 4 Vandenbroucke St.
Amant...Malik, Cir Res, 2012
Brown...Reynolds, Exp Cell Res,
2009
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T916 N/A N/A N/A T916 phosphorylation is high in renal cell
carcinoma, but T916 is not required in
transforming ability
1, 2, 3, 4 Kourtidis...Anastasiadis, PLoS
One, 2015
Tyrosine residue Tyrosine kinase
Y112 Fyn Overexpression in NIH3T3 cells reduces stress ﬁber
formation.
Phosphorylation lowers p120
assn. w/ RhoA, Rac and Vav2,
in preference to E-cadherin
binding.
In contrast to wild-type p120, the Y112E mutant
has little effect upon stress ﬁbers.
1, 2, 3 Castano...Dunach, Mol Cell
Biol, 2007
Y112, Y217 Src/Fyn N/A Wnt pathway, p120 release
from cadherin and LRP5/6 to
enable assn. with Vav2 and
Rac1.
P120 Y112E and Y217E phosphomimic mutants
have reduced assn. w/ Rac1 and Vav2. Mutant
failed to rescue gastrulation delay upon p120
depletion (Y112E).
1, 2, 3 Valls...Dunach, J Cell Sci, 2012
Y217 Src v-Src overexpression reduces E-cadherin mediated
cell aggregation.
v-Src mediated signaling P120 Y217F mutant increases cell aggregation. 1,2,3 Ozawa...Ohkubo, J Cell Sci,
2001
Y217, Y228 Src N/A Src and cadherin-related
pathways
Src phos. of p120 Y217 and Y228 promotes p120
assn. w/ and inhib. RhoA.
1, 2, 3 Castano...Dunach, Mol Cell
Biol, 2007
Y228 N/A Certain carcinoma cell lines (e.g. HCT116, HT29 and
A431) show high levels of Y228 phosphorylation.
EGFR activation induces p120
Y228 phosphorylation.
Mutation of Y228 and 7 other tyrosine residues
in p120 did not prevent junction formation or
compaction of cultured cells.
1, 2, 3 Mariner...Reynolds,J Cell Sci,
2004
Y228 Src Activation of Src family kinase is common in
Glioblastoma multiforme (GBM).
VEGF/Src family kinases. Y228 phosphorylation is high in highly or
moderately invasive GBM.
1, 2, 3 Huveldt...Anastasiadis, PLoS
One, 2013
Y228 N/A P120 Y228 phosphorylation is high in renal cell
carcinoma and breast cancer cells.
Src family kinases. Mutation of p120 simultaneously at 8 tyrosine
sites (including Y228) reduces tumorigenic
potential.
1, 2, 3 Kourtidis...Anastasiadis, PLoS
One, 2015
Tyrosine residue Phosphatase
Y296 SHP-1 N/A EGF/Src N/A 1, 2, 3 Frank...Bohmer, J Biol Chem,
2004
Y335 PTP-PEST Silencing PTP-PEST reduces p120-E-cadherin
association and increases p120's cytoplasmic pool.
Ectopic expression of PTP-PEST suppresses cell
migration in colon carcinoma cells.
Stable knock-down PTP-PEST reduces junction
integrity, enhances Rac1 and reduces RhoA activity,
and generates a mesenchymal-like phenotype in colon
carcinoma cells.
PTP-PEST is essential for
junction assembly via effects
upon p120 and small-GTPases.
P120 point mutant Y335F fails to associate with
Vav2, activate Rac1 or induce epithelial
migration (HCT116).
1, 2, 3, 4 Espejo...Sastry, J Cell Sci, 2014
Espejo...Sastry, Am J Physiol,
2010
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was determined via deep sequencing that the absence of p120's splice re-
gion B correlates with some colorectal cancers [146]. Potential phospho-
residues do not exist in splice region B, although sites present nearby
(S879, T916) may conceivably respond to the presence/absence of splice
regionB, andbe relevant to tumorigenesis. Taken together, the phosphor-
ylation status of p120-catenin is likely to prove relevant to cancer pro-
gression, with a number of the involved residues being isoform speciﬁc.
P120 may participate in epithelial-to-mesenchymal transitions
(EMTs) in tumor progression, with for example, a switch from short-
to-long p120-isoforms occurring in response to factors including
Zeppo1 (ZNF703) [125]. In some tumor cells lacking E-cadherin, and
in cells over-expressing Src, p120-catenin facilitates cell invasion and
anchorage-independent growth via effects upon Rho/ROCK signaling.
Studies of breast, colon and lung cancer cells indicate that heightened
levels of cytosolic p120 contribute to the invasiveness of tumors
deﬁcient for E-cadherin [11,22,123,161]. For example, cytosolic p120-
catenin facilitates anchorage-independent tumor growth and metasta-
sis in invasive lobular carcinoma cells via affects upon RhoA [122].
Considering that p120's phosphorylation status is responsive to being
localized at the plasma membrane via cadherin, and its release from
cadherin is further responsive to phosphorylation, p120's cadherin-
and phospho-modulated movements to the cytoplasm potentially
contribute to the EMT process. Thus, changes in p120's intracellular
phosphorylation, localization and isoform use in EMT are proposed to
facilitate cancer progression (reviewed in [70,88,121]).Fig. 3. Isoform-speciﬁc mechanisms of p120-catenin. Model of isoform-speciﬁc roles of p120-ca
receptors, act to prevent destruction of p120-isoform 1, such that it is more stable and therefor
CanonicalWnt-signals have a lesser protective effects upon shorter p120-isoforms, since the sho
canonical Wnt signals, (e.g. lack ofWnt-ligand binding to Frizzled/LRP5/6 co-receptors), p120-
APC, GSK3beta and CK1alpha), and delivered to the proteasome for elimination (not shown). B.
Zeppo1, suggesting the potential role of p120-isoforms during epithelial-mesenchymal transit
modulate p120's splicing events [142]. Since p120-isoform 1 more effectively inhibits RhoA th
cell process-extension, motility or invasion. C. P120-catenin binds and displaces the Kaiso repre
beta-catenin and alpha-catenin (etc.) are not depicted, and N-cadherin is shown without assocFurtherworkwith cell lines aswell as lung and breast tumor samples
has indicated that E-cadherin is a key determinant of p120-catenin local-
ization and activity [29,127,161]. In epithelial cells lacking E-cadherin,
p120 is often present in the cytoplasm where in common with p120
still at junctions [69,71,144], it interacts with small-GTPases modulating
the cytoskeleton [5,11,103,107,122,125,161] (reviewed in [70,121]), or
reaches the nucleus to engage in gene control [30,31,49,59,77,114,140,
160]. Acting through small-GTPases such as RhoA and Rac1 in EMT or
cancer, p120-isoform 1 might be predominant in promoting motility
and invasiveness [154]. Since certain phospho-residues exist only
in p120-isoform 1 (S6, S8, S11, S15, T47), and as noted modulate p120
stability in response to Wnt-signals or the kinase Dyrk1A, they may
prove worthy of further examination in the context of tumor formation
or metastasis.
6. Summary
In summary, the collective evidence is that isoform and phosphory-
lation use in p120-catenin is relevant to cell behaviors in development,
homeostasis and pathology. Among others, upstream inputs include the
presence versus absence of cadherins, growth factor signaling and
possibly canonical Wnt signals. Future study of p120 biology will need
to focus more on factors and mechanisms that determine isoform
expression or retention, localization and activity, and the relevance of
phosphorylation as well as additional covalent modiﬁcations in modu-
lating p120's functional roles. Based upon a recent report showingtenin. A. Canonical Wnt signals, initiated byWnt-ligand binding to the LRP5/6 and Frizzled
e active, as in the de-repression of the transcriptional repressor Kaiso depicted in (C) [49].
rter isoforms 2–4 lack the destruction box found only in isoform1. That is, in the absence of
isoform 1 is acted upon by the destruction complex (containing components such as Axin,
Switches in p120-catenin isoforms have been observed upon ectopic expression of Snail or
ion (Fig. 3B) [99,125]. In addition, epithelial cell type speciﬁc regulators ESRP1 and ESRP2
an isoform 3, consequent effects arise that relate to cytoskeletal modulation, and thereby
ssor from its consensus binding sites, leading to gene activation [49,50,160]. For simplicity,
iated catenins.
111J.Y. Hong et al. / Biochimica et Biophysica Acta 1863 (2016) 102–114that the pp120 antibody, which is widely used in p120 biology, does not
detect p120 that is phosphorylated at T916 (nearby the pp120 epitope),
we likely need to reevaluate p120's localization and expression levels in
multiple tissues and cancers using other reagents [70]. While nontrivial
to develop, we need additional p120 antibodies that speciﬁcally report
on a wider range (e.g. see Table) of p120's phosphorylation states, so
as to better evaluate their relevance in development and
tumorigenesis; this importantly includes having such phospho- or
dephospho-speciﬁc antibodies to help identify and evaluate upstream
regulatory pathways that direct p120's functions. At present, there is
little known about most p120 phosphorylation events with respect to
embryogenesis or disease. Ideally, select conditional and inducible
mouse knock-ins of p120-isoforms engineered to contain phospho- or
dephospho-mimic residueswill become available to assess the develop-
mental signiﬁcance of such covalentmodiﬁcations in vivo. For example,
given that the phosphorylation of S288, T916 and Y228 are high in
certain tumor samples, these residues would be interesting to probe.
Finally, because p120-catenin is but one member of the larger p120-
catenin sub-family that exists in vertebrates (reviewed in [54,86,107]),
with the plakophilin–catenins representing yet another related sub-
family (reviewed in [10,46]), what is determined concerning p120 should
provide insight upon multiple catenins and their respective isoforms
having roles at cell–cell junctions, and in the cytoplasm and nucleus.
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